Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,248 public trials 1,189 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

High-dose ICE With Amifostine

NCT00003657

Conditions
AIDS-related Kaposi sarcoma, Adnexal Diseases, Bladder Cancer, +80 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)

NCT00842712

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Antwerpen (Edegem), Belgium
  • Research Site Brasschaat, Belgium
  • Research Site Brussels, Belgium
  • Research Site Gosselies, Belgium
View all 44 locations
View Trial Details
Completed

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

NCT00932451

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
View all 280 locations
View Trial Details
Completed

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

NCT00932893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Arkansas for Medical Research, Winthrop Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
View all 264 locations
View Trial Details

Related conditions